Sectoral Asset Management’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,896
Closed -$531K 115
2023
Q4
$531K Sell
17,896
-446,216
-96% -$8.89M 0.23% 76
2023
Q3
$7.37M Buy
464,112
+27,665
+6% +$460K 1.43% 24
2023
Q2
$8.24M Sell
436,447
-564,997
-56% -$6.67M 1.37% 26
2023
Q1
$3.85M Buy
1,001,444
+197,500
+25% +$842K 0.74% 57
2022
Q4
$3.99M Sell
803,944
-44,800
-5% -$243K 0.77% 56
2022
Q3
$4.06M Sell
848,744
-91,500
-10% -$482K 0.8% 57
2022
Q2
$4.23M Buy
940,244
+61,400
+7% +$267K 0.85% 49
2022
Q1
$4.18M Buy
+878,844
New +$4.87M 0.74% 54
2019
Q2
Sell
-58,013
Closed -$157K 104
2019
Q1
$157K Sell
58,013
-77,300
-57% -$335K 0.02% 92
2018
Q4
$650K Buy
135,313
+114,300
+544% +$694K 0.09% 68
2018
Q3
$199K Buy
+21,013
New +$202K 0.02% 137
2014
Q4
Sell
-2,269,597
Closed -$24M 72
2014
Q3
$24M Sell
2,269,597
-948,679
-29% -$10.7M 1.01% 30
2014
Q2
$38.1M Sell
3,218,276
-405,510
-11% -$5.09M 1.62% 26
2014
Q1
$54.1M Buy
3,623,786
+110,504
+3% +$1.74M 2.23% 20
2013
Q4
$51.5M Sell
3,513,282
-139,611
-4% -$2.15M 2.22% 20
2013
Q3
$62.2M Sell
3,652,893
-2,766,091
-43% -$48.6M 2.99% 9
2013
Q2
$106M Buy
+6,418,984
New +$104M 3.15% 13

Other funds holding IMGN

Sectoral Asset Management's IMGN Position: Q1 2024 in Review

Sectoral Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 17,896 shares — an estimated $531K sold.

Sectoral Asset Management first reported a position in IMGN in Q2 2013 and held it in 17 quarters. The position peaked at $106M in Q2 2013. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Sectoral Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 17,896 Immunogen Inc shares in Q1 2024, an estimated $531K.
  • Sectoral Asset Management first reported a position in Immunogen Inc in Q2 2013 and held it in 17 quarters.
  • Sectoral Asset Management's Immunogen Inc position peaked at $106M in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.